- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Breast Ductal Carcinoma In Situ in Hong Kong
Total 911 results
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerFrance, Spain, United States, Belgium, Netherlands, Canada, Italy, Singapore, Korea, Republic of, Czechia, Germany, Hong Kong
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Blueprint Medicines CorporationCompletedHepatocellular Carcinoma (HCC)China, Korea, Republic of, Taiwan, Hong Kong, United Kingdom, United States, France, Spain, Switzerland, Singapore, Germany, Italy
-
Cullinan Therapeutics Inc.RecruitingNon Small Cell Lung Cancer | EGFR Exon 20 MutationUnited States, Taiwan, Spain, Korea, Republic of, Japan, Singapore, Italy, Netherlands, Hong Kong
-
PfizerCompletedCarcinoma, Non-small CellUnited States, Taiwan, Korea, Republic of, Japan, Hong Kong
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
MedImmune LLCActive, not recruitingHepatocellular CarcinomaUnited States, Italy, Spain, Taiwan, Korea, Republic of, China, Hong Kong, Japan, Singapore
-
National Cancer Institute (NCI)Active, not recruitingTriple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7United States
-
US Department of Veterans AffairsOrtho DermatologicsCompletedCarcinoma, Squamous Cell | Carcinoma, Basal Cell | Skin NeoplasmsUnited States
-
BayerCompletedBreast NeoplasmsBelgium, Spain, Hong Kong, Taiwan, Japan, United States, Austria, Singapore, Israel, United Kingdom, Italy, Korea, Republic of, France, Poland, Switzerland, Germany, Norway
-
Shanghai EpimAb Biotherapeutics Co., Ltd.CovanceRecruitingNeoplasms | Neoplasm Metastasis | Non-Small-Cell Lung CancerUnited States, China
-
NovartisCompletedBreast CancerUnited States
-
Rutgers, The State University of New JerseyRecruitingRectal Cancer | Colon CancerUnited States
-
SC Liver Research Consortium, LLCBayerTerminated
-
AstraZenecaRecruitingHepatocellular Carcinoma | Biliary Tract CancerChina, Spain, Korea, Republic of, Italy, United Kingdom, United States, Japan, Taiwan, Hong Kong
-
Novartis PharmaceuticalsCompleted
-
PfizerCompletedNSCLC (Non-small Cell Lung Cancer)Hong Kong, China, Taiwan, Malaysia, Thailand
-
Celldex TherapeuticsCompletedBreast CancerUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerChina, United States, France, Italy, United Kingdom, Taiwan, Turkey, Egypt, Germany, Hong Kong, Belgium, Canada, Russian Federation, Lebanon, Japan, Australia, Greece, Korea, Republic of, Ireland, Peru, Argentina, Brazil, Colombia, South... and more
-
AstraZenecaCompletedNon-Small Cell Lung CancerItaly, Spain, France, Korea, Republic of, Hungary, Japan, China, Taiwan, Hong Kong, Germany, Russian Federation
-
AstraZenecaCompletedNon Small Cell Lung CancerVietnam, Philippines, China, Hong Kong, Taiwan, Thailand, India
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States, Taiwan, Belgium, Israel, Australia, Hong Kong, China, Czech Republic
-
ZionexaGE Healthcare; Medpace, Inc.; Simbec-Orion GroupRecruitingMetastatic Breast CancerUnited States
-
Precision TherapeuticsUnited States Department of DefenseTerminatedBreast CancerUnited States
-
Novartis PharmaceuticalsRecruitingCarcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer of the Lung | KRAS G12C Mutant Solid Tumors | Carcinoma, ColorectalUnited States, Japan, Australia, Germany, Italy, Spain, Canada, Denmark, Korea, Republic of, Taiwan, Belgium, Hong Kong, China, France, Singapore, Netherlands
-
Gilead SciencesArcus Biosciences, Inc.RecruitingLung Cancer | Advanced or Metastatic Non-Small-Cell Lung Cancer | Resectable Non-Small-Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Hong Kong, Israel, United Kingdom
-
GlaxoSmithKlineTerminatedNeoplasms, Breast | Relapsed Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerCanada, Germany, Korea, Republic of, Panama, Spain, Turkey, Brazil, Colombia, France, Hungary, Russian Federation, Taiwan, Thailand, Czechia, Italy, Estonia, Peru, South Africa, Sweden, Poland, Israel, Hong Kong, Mexico, Guatemala, Arge... and more
-
National Cancer Institute (NCI)CompletedObesity | Colorectal Cancer | Adenomatous PolypCanada, United States
-
Jennerex BiotherapeuticsCompletedHCC | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, United States, Hong Kong, Canada, Germany, France, Taiwan
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Belgium, Korea, Republic of, Hong Kong, United Kingdom, Japan, Italy, Spain, Singapore, Taiwan, Germany, France, New Zealand
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
-
TakedaCompletedNon-small Cell Lung Cancer (NSCLC)Hong Kong, France, Canada
-
PfizerCompletedBreast NeoplasmsUnited States
-
AstraZenecaRecruitingStage II-IIIB Non-small Cell Lung CarcinomaSpain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
-
Janssen Research & Development, LLCTerminatedCarcinoma, HepatocellularChina
-
BayerTerminatedBreast NeoplasmsSpain, Canada, United States, Finland, Austria, Singapore, Czechia, Israel, Korea, Republic of, Netherlands, Taiwan, United Kingdom, Poland, Germany, Hong Kong, Denmark, Switzerland, Ireland, France, Norway
-
BayerCompletedCarcinoma, HepatocellularJapan, China, Slovakia, Croatia, France, Hungary, Indonesia, Korea, Republic of, Malaysia, Singapore, Spain, Sweden, Thailand, Philippines, Colombia, Czech Republic, Hong Kong, Italy, Kazakhstan, Mexico, Romania, Russian Federation, Ukrain... and more
-
AmgenRecruitingSmall Cell Lung CarcinomaUnited States, Spain, Austria, Switzerland, United Kingdom, France, Australia, Germany, Japan, Taiwan, Poland, Hong Kong, Netherlands
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis PharmaceuticalsTerminatedLung CancerUnited States
-
Translational Research in OncologyBayerRecruitingCarcinoma, HepatocellularKorea, Republic of, United States, Taiwan, Spain, Japan, France, Georgia, Germany, Turkey, Italy, Belgium, Hong Kong, Serbia
-
Spectrum Pharmaceuticals, IncCompletedBreast CancerUnited States
-
BiogenCompletedBreast CancerUnited States, Russian Federation, Australia, Belgium
-
BeiGeneActive, not recruitingRecurrent or Metastatic Nasopharyngeal CancerChina, Taiwan, Thailand
-
TularikTerminatedHepatocellular CarcinomaUnited States, Russian Federation, United Kingdom, Singapore, Thailand, Ukraine, Brazil, China, Poland, Puerto Rico, South Africa
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Belgium, Canada, France, Spain, Turkey, Japan, Egypt, Germany, Austria, Poland, Sweden, United Kingdom, Thailand, Hungary, Australia, Italy, Netherlands, Brazil, Hong Kong, Czech Republic, Korea, Republic of, New Zealand and more
-
Dana-Farber Cancer InstituteGenentech, Inc.Recruiting
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan